Project Details
Description
Autophagy-mediated sensitization of high-grade serous ovarian cancer cells to PARP inhibitor treatment in the setting of BRCA1/2 mutation status
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/22 → 7/31/23 |
Funding
- MN OVARIAN CANCER ALLIANCE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.